Skip to main content
Caplight Logo









Medimaps Group

Medimaps Group

Private
GenevaHealthcare & Life Scienceshttps://www.medimaps.ai/

Last Round

VC Round

Dec 1, 2021

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Medimaps Group is a medical technology company that develops AI-driven imaging software for bone microarchitecture assessment and fracture risk prediction.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

Trabecular Bone ScoreTBSbone microarchitecturemedical imaging AIfracture risk assessmentosteoporosis managementclinical AISoftware as a Medical DeviceSaMDmusculoskeletal AIMSK AIDXA scan analysisbone healthcontract research organizationCROopportunistic screeningSoftware-as-a-DeviceSaaD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medimaps Group Comparables

Compare Medimaps Group with similar companies based on industry and business-model similarity.

Medimaps Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
16 Bit Inc.
84%
3D-Shaper Medical S.L.
83%
ImageBiopsy Lab
82%

Medimaps Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 1, 2021

Key People

Founding team and executive leadership

Vincent Zwaans

COO

Executive Team

Medimaps Group Investors

Notable investors and investment history

Medimaps Group investors
InvestorRounds
Verve VenturesVC Round
Swisscom VenturesVC Round
Swiss Entrepreneurs FundVC Round
Swisscanto Private EquityVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors grew 54% MoM, from 3.7K to 5.6K.

  • Feb 25, 2025

    Grew 16% QoQ, from 57 to 66 employees.

Medimaps Group Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Medimaps Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Medimaps Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersGeneva
Employee Range69
Year Founded2012
Last FundingDec 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?